The Nucleosome Remodeling and Deacetylase (NuRD) complex is essential for development in complex animals but has been refractory to biochemical analysis. We present the first integrated analysis of the architecture of the native mammalian NuRD complex, combining quantitative mass spectrometry, covalent cross-linking, protein biochemistry and electron microscopy. NuRD is built around a 2:2:4 pseudo-symmetric deacetylase module comprising MTA, HDAC and RBBP subunits. This module interacts asymmetrically with a remodeling module comprising one copy each of MBD, GATAD2 and CHD subunits. The previously enigmatic GATAD2 controls the asymmetry of the complex and directly recruits the ATP-dependent CHD remodeler. Unexpectedly, the MTA-MBD interaction acts as a point of functional switching. The transcriptional regulator PWWP2A modulates NuRD assembly by competing directly with MBD for binding to the MTA-HDAC-RBBP subcomplex, forming a 'moonlighting' PWWP2A-MTA-HDAC-RBBP complex that likely directs deacetylase activity to PWWP2A target sites. Taken together, our data describe the overall architecture of the intact NuRD complex and reveal aspects of its structural dynamics and functional plasticity.
INTRODUCTION
The physical organization of DNA is a critical determinant of genome function. ATP-dependent chromatin remodeling enzymes use a conserved DNA translocase domain to alter the positions, occupancy and composition of nucleosomes, thereby regulating the availability of DNA for transcription, replication or repair. Chromatin remodelers typically exist as large multi-subunit complexes in vivo, and despite recent high-resolution structures of nucleosomes bound to the
RESULTS

Subunit stoichiometry measurements partition the NuRD complex into symmetric and asymmetric modules with distinct catalytic activities
We purified native mammalian NuRD complex from murine erythroleukemia cells using our previously established protocol (Figure 1a, (44) ). This strategy also yields a complex lacking the CHD subunit, which we have previously termed the Nucleosome Deacetylase (NuDe) complex. To interrogate the subunit composition of these complexes, we carried out data-independent acquisition mass spectrometry (DIA-MS) (45) using subunit-specific 13 C/ 15 N-labelled peptides as internal standards. This approach provides rigorous quantification of NuRD subunits together with information on paralogue composition (Supplementary Results, Figure S1c ).
For both NuDe and NuRD, we derived ratios of ~2:2:7:1:1 for MTA:HDAC:RBBP:MBD:GATAD2 (Figure 1b, Supplementary Data 2) . CHD4 was consistently sub-stoichiometric, reflecting the fact that complete separation of NuDe and NuRD was not possible because of overlap in their sedimentation profiles. The numbers are calculated relative to an MTA:HDAC ratio of 2:2 (Supplementary Results), based on the crystal structure of this complex (27) .
Of all subunits, RBBP displayed the highest variability between samples (Figure 1b) . The ratio of 7
RBBPs per NuRD complex was unexpected; however, it is the FOG1-RBBP interaction that was used as the affinity purification 'handle', most likely leading to an excess of NuRD-free RBBPs.
Given this variability, we sought to more rigorously define the RBBP content of the complex.
Previous structural and biochemical work shows that it is the C-terminal half of MTA1 that is responsible for recruiting RBBPs to the NuRD complex (25, 28, 30) . To corroborate this conclusion, we expressed and purified a subcomplex comprising HDAC1, the N-terminal half of MTA2 (residues 1-429; MTA N ) and MBD3 GATAD2CC (MTA N -HDAC-MBD GATAD2CC , Figure S2a ).
MBD3 GATAD2CC is full-length MBD3 stabilized by fusion to the coiled-coil domain of murine GATAD2A (residues 133-174), with which it dimerizes (46) (Figure S1a) . Quantitative DIA-MS analysis showed that this MTA N -HDAC-MBD GATAD2CC complex contains little or no RBBP protein, consistent with the idea that RBBP subunits are recruited to the complex solely by the C-terminal half of MTA (Supplementary Data 2) . We confirmed this conclusion by expressing an MTA C -RBBP subcomplex comprising RBBP4 and the C-terminal half of MTA1 (residues 449-715) ( Figure S2a) ; DIA-MS analysis showed that this complex has a stoichiometry of ~1:2.5 (Figure   1b, Supplementary Data 2) -much closer to the expected 1:2 ratio. We likewise co-expressed and purified a subcomplex comprising MTA2, HDAC1 and RBBP7 (MTA-HDAC-RBBP, Figure S2a ), which yielded a subunit ratio of ~2:2:4 (Figure 1b, Supplementary Data 2) .
As an orthogonal approach, we directly measured the molecular mass of the NuDe and NuRD complexes using size exclusion chromatography coupled to multiangle laser light scattering (SEC-MALLS). In both cases, we observed masses that were within 7% of the expected mass for a 2:2:4:1:1:1 complex (MTA:HDAC:RBBP:MBD:GATAD2:CHD4, Figure S3a , Supplementary Results). Taken together, our data argue that the mammalian NuRD complex has a stoichiometry of 2:2:4:1:1:1 (MTA:HDAC:RBBP:MBD:GATAD2:CHD4). By integrating these findings with published biophysical and structural work on Drosophila NuRD and several subcomplexes (24, (27) (28) (29) (30) 47) , we can confidently conclude that NuRD is built from a symmetric 2:2:4 MTA-HDAC-RBBP deacetylase module and an asymmetric 1:1:1 MBD-GATAD2-CHD remodelling module.
The DIA-MS data also allowed us to quantify paralogue abundance in the native NuRD and NuDe complexes isolated from MEL/HEK293 cells. As shown Figure S1c , a distinct preference for HDAC1 over HDAC2 is observed, whereas MTA3 or MBD2 are nearly absent from our complex.
The two GATAD2 paralogues are similarly abundant. Little or no CHD3 or CHD5 were detected in our samples.
XLMS data establish the core architecture of the NuRD complex
We next asked how the deacetylase and remodeling modules of NuRD are physically connected.
Our prior work shows that the only interaction linking these two modules is between MTA and MBD; no direct interactions between the deacetylase module (MTA-HDAC-RBBP) and either GATAD2 or CHD were identified (25) . Our ability to co-express and purify a stable MTA N -HDAC-MBD GATAD2CC subcomplex (see above) also points towards MBD bridging the two halves of the complex, and shows that neither the C-terminal half of MTA nor the RBBPs are required to couple the two halves of the complex. A structure of the MBD-GATAD2 complex (24) indicates that these two proteins directly interact, meaning that GATAD2 is recruited to the complex by MBD. Consistent with this idea, co-expression of MTA2, HDAC1, MBD3 and GATAD2A yields a stable complex containing all four proteins (MTA-HDAC-MBD-GATAD2, Figure S2a,b) .
Notably, this complex recruits significant amounts of endogenous CHD, whereas the MTA N -HDAC-MBD GATAD2CC complex does not (Figure S2a,b) . We therefore conclude that the architecture of NuRD consists of a dimeric deacetylase core of MTA, HDAC and RBBP subunits that directly interacts with MBD; in turn MBD binds GATAD2 and it is GATAD2 alone that dictates the recruitment of CHD and ultimately confers DNA translocase activity on the full complex (Figure 2a) .
To examine the placement of subunits and, in particular, how the MBD subunit couples the two halves of the complex, we carried out covalent crosslinking combined with mass spectrometry (XLMS) on NuRD and several subcomplexes. These experiments yielded 752 unique XLs that were highly conserved across MTA N -HDAC-MBD GATAD2CC , MTA-HDAC-MBD-GATAD2, MTA-HDAC-RBBP, NuDe and NuRD complexes (Figure S4a, Supplementary Data 1) .We observed a high density of XLs between: (i) RBBP and the C-terminal half of MTA; (ii) HDAC and the Nterminal half of MTA; (iii) MBD and the N-terminal half of MTA; and (iv) the first coil-coiled region (~residues 136-178) of GATAD2 and MBD3. All these pairs have been previously reported to be the direct points of contact in the complex (24, 25, (27) (28) (29) (30) (31) .
Of these XLs, 174 are between pairs of residues in known structures of subunits and subcomplexes.
Ninety-four percent (range 88-100%) of these are consistent with the structural data (Figure S4b , Supplementary Data 1), providing a strong argument that these subcomplex structures recapitulate the architecture of the full NuRD complex in solution.
A set of 120 XLs connects pairs of domains that have known or readily modeled structures but for which relative positions in the NuRD complex are unknown. We have defined these domains as shown in Figure S1 : GATAD2A 136-178 (GATAD2 CC1 : the first coiled-coil domain of GATAD2A). XL-driven rigid-body docking in HADDOCK (48) yields a domain architecture that is consistent with 93% (112/120) of the XLs (Figure 2b) . This model places the BAH domain at the distal ends of the MTA ES -HDAC dimer of dimers where it is juxtaposed with the MBD MBD domain. In turn, the MBD-GATAD2 coiled-coil domain packs against the MBD MBD domain, despite the two domains being separated by ~145 residues of sequence that is disordered in isolation (46) . Only one copy of MBD3 is placed in the model because of the complex stoichiometry dictated by our DIA-MS data.
In our model, the MTA H helix lies directly adjacent to the HDAC active site. Figure 2c highlights the well-described phenylalanine at the entry to the active site (Phe150, blue) and we have indicated the degree of access to the active site by modelling in a known HDAC inhibitor, hydroxamic acid (based on a structure of HDAC8; PDB: 5FCW) (49) . This observation suggests that the MTA subunits in NuRD could potentially modulate HDAC activity.
The MBD subunit harbours a region of ~145 residues (residues 69-216, MBD IDR ) that has been demonstrated to be disordered in isolation (46) but which is predicted to be ordered by programs such as PONDR (50) . We observed 162 XLs to residues in MBD IDR , but only in the N-terminal half of the sequence (Figure S4c) . Approximately half of the XLs were to other unstructured residues in MBD3 but 92 were to structured portions of HDAC, MTA N , GATAD2 CC1 , MBD CC and MBD MBD , forming a relatively contiguous surface against which this region might pack (Figure 2d ).
Concordant with these data, Williams and colleagues demonstrated that the N-terminal two-thirds of this region (but not the C-terminal third) can immunoprecipitate HDAC2, MTA2 and RBBP4 and that point mutations in this region abrogate the interaction (46) .
One hundred and seventy-seven XLs were observed within and between RBBP proteins and the Cterminal half of MTA (which encompasses the two RBBP binding sites R1 and R2 as well as a ~100-residue region that is predicted to be disordered, Figure S1a ). Of these, 69 XLs occur within previously published crystal structures of the MTA1 R1 -RBBP4 and MTA1 R2 -RBBP4 subcomplexes and were highly consistent with the structural data (63/69 or 91%, Figure S4c ). An additional 7
XLs were between structured regions but not in published crystal structures and we were able to use HADDOCK, together with published structures, to generate a model of MTA C -RBBP 2 . However, while this model fitted within our published low-resolution electron microscopy (EM) map of the complex (28), only 4 out 7 XLs (~57%) could be satisfactorily mapped within the crosslinker distance constraints ( Figure S4d) ; this fulfilment rate is far lower than the 93% observed for the MTA N -HDAC-MBD-GATAD2 core complex model above and might reflect substantial dynamics in this region of the complex. (Figure 2f) . The remaining portion of the complex, namely CHD and the C-terminal half of GATAD2, displayed very few inter-subunit XLs, meaning that their locations cannot be confidently modelled. This lack of XLs suggests that the CHD-GATAD2 subcomplex also displays considerable dynamics.
GATAD2 controls the asymmetry of the NuRD complex
Our model indicates that there are two equivalent sites on the MTA-HDAC subcomplex that could accommodate an MBD subunit, raising the question as to why only one MBD is observed in the full NuRD complex. We therefore made DIA-MS measurements on the MTA N -HDAC-MBD GATAD2CC subcomplex. Unexpectedly, we derived a 2:2:2 stoichiometry (Figure 3a) -consistent with the symmetry of the HDAC-MTA-RBBP subcomplex and our crosslink-directed modelling but inconsistent with the native stoichiometry we determined for NuRD. The finding that in vitro reconstituted MTA N -HDAC-MBD GATAD2CC forms a 2:2:2 complex was corroborated by SEC-MALLS data (Figure 3b) , which yielded a MW of ~290 kDa, in close agreement with the 288-kDa mass predicted. FLAG-tagged MBD3 can also immunoprecipitate untagged MBD3 when both are co-expressed with HDAC and MTA, confirming that there are two MBD-compatible binding sites within the one complex ( Figure S5 ).
Using negative stain electron microscopy (EM), we recorded 325 micrographs of the purified MTA N -HDAC-MBD GATAD2CC complex (Figure 3c and S2c). From these micrographs we generated class averages that represent different orientations of the complex. The dataset was relatively homogeneous, so using 3D classification and refinement routines in RELION, we obtained a lowresolution structural envelope (29 Å according to the FSC 0.143 criterion) that reveals a bi-lobed structure with an approximate two-fold symmetry (Figure 3d ), in line with our stoichiometry data.
The model derived from our XLMS data is overall well accommodated within this density envelope (Figure 3d ). Only the MTA ZF domain significantly protrudes from the map, perhaps indicating that the ZF domain is dynamic; this is likely, given it is connected to the rest of MTA N by a 36-residue linker that is predicted to be disordered. The envelope presented in Figure 3d has been segmented and colored according to occupancy by the various structural domains that are represented in our XLMS-derived model. The wire mesh indicates regions of the map for which no model density is currently assigned. These are likely indicative of regions of sequence for which no structures are available, specifically the C-terminal ~100 residues of HDAC and ~145 residues of MBD IDR . Encouragingly, the largest part of this unassigned density lies in the position predicted for MBD IDR from our XLMS data (Figure 2d and 3d) .
The unexpected 2:2:2 stoichiometry of the MTA N -HDAC-MBD GATAD2CC complex raised the question of why only one MBD is found in the intact NuDe/NuRD complexes. We hypothesized that it is the presence of the GATAD2 subunit that prevents binding of a second MBD subunit in the larger complexes. Indeed, when we co-expressed GATAD2A with MTA2, HDAC1 and MBD3 (the MTA-HDAC-MBD-GATAD2 complex, Figure S2a ), the expected 2:2:1:1 stoichiometry was restored, as judged by DIA-MS (Figure 3a, Supplementary Data 2) . We therefore conclude that the GATAD2 subunit is responsible not only for recruiting CHD remodelling activity to the NuRD complex but also for controlling the asymmetry of the complex.
RBBP subunits introduce substantial conformational dynamics into the NuRD, NuDe and
MTA-HDAC-RBBP complexes
We next analysed three other (sub)complexes by negative-stain EM. Datasets were collected for the MTA-HDAC-RBBP, NuDe and NuRD complexes (Figure S2c and S6) . In each case, particles were observed that could be aligned and classified to produce 2D class averages (Figure 4a) .
Examination of the classes obtained for MTA-HDAC-RBBP made it clear that significant shape heterogeneity exists, even for particles of a similar apparent size. Given the relative homogeneity of the MTA N -HDAC-MBD GATAD2CC complex preparation, we conclude that the MTA C -RBBP 2 units exhibit considerable dynamics relative to the MTA N -HDAC-MBD GATAD2CC core. Because of this dynamic behavior, we did not generate 3D maps but rather restricted our analysis to the 2D classes, which we interpreted as projections of conformational variants of the complex. Figure 4b shows that 2D classes for the MTA-HDAC-RBBP complex can be readily interpreted as comprising a central MTA N -HDAC module (magenta and orange, EMD-3399, (30) ) and two MTA C -RBBP 2 modules (blue, EMD-3431, (28) ) that can rotate relative to the MTA N -HDAC core. The only difference between the models shown is the relative rotation of the MTA C -RBBP 2 units.
Analysis of the NuDe data revealed a similar pattern (Figure 4c ). GATAD2 is likely to be highly dynamic and therefore does not give rise to clear additional density. Interpretation of the NuRD data is more challenging, as there is a lack of reliable 3D structural data for most of CHD4. Nonetheless, a similar type of conformational heterogeneity is apparent (Figure 4a) , as expected for our model.
PWWP2A competes directly with MBD-GATAD2-CHD for binding to the MTA-HDAC-
RBBP module of NuRD
Our data demonstrate that MBD and GATAD2 form a nexus that connects two symmetrymismatched modules of NuRD -namely the remodelling and the deacetylase modules. This finding raises the question as to whether either module has a physiological role outside of the NuRD complex. We and others recently demonstrated that PWWP2A, a transcriptional regulator that is important for neural crest differentiation, can immunoprecipitate HDAC, MTA and RBBP but not other NuRD subunits (42, 51) . PWWP2A therefore appears to selectively bind MTA-HDAC-RBBP but not intact NuRD. To better understand this interaction, we expressed FLAG-PWWP2A with combinations of HDAC1, MTA1, MBD3 and GATAD2B and carried out pull-downs. As expected, FLAG-PWWP2A pulled down MTA1 and HDAC1 (Figure 5a, lane 5) . Strikingly, however, the additional co-expression of either MBD3 or a combination of MBD3 and GATAD2B (lanes 4 and 6, respectively) made no difference -only HDAC1 and MTA1 were retained by PWWP2A. In contrast, when PWWP2A was absent, MBD3 and GATA2B did form a complex with the MTA-HDAC core, as expected (Figure 5b, lanes 3 and 4) . These data demonstrate that PWWP2A competes directly with MBD for binding to the deacetylase module of NuRD.
To corroborate this finding, we collected XLMS data on a PWWP2A-MTA-HDAC-RBBP complex (Supplementary Data 1). 146 unique XLs were observed between PWWP2A and either HDAC or the N-terminal half of MTA. Figure 5c shows that the set of residues in MTA1 and HDAC1 that crosslink to PWWP2A closely matches those that crosslink to MBD in the MTA N -HDAC-MBD GATAD2CC complex. These data together support the conclusion that PWWP2A directly competes with MBD for binding to a common surface on the MTA-HDAC core complex. In an in vivo context, this provides a mechanism by which PWWP2A can recruit the deacetylase activity of NuRD to specific genomic loci without co-recruiting the remodelling activity of the CHD subunit.
DISCUSSION
NuRD assembly is regulated at an interface between separable histone deacetylase and DNA translocase units
The data presented here define the subunit stoichiometry of the mammalian NuRD complex, elucidate key features of NuRD architecture and demonstrate that the NuRD complex is built from two separable structural entities that have distinct catalytic activities. One of these entities -MTA-HDAC-RBBP -has two-fold symmetry, can be readily purified and harbours the histone deacetylase activity. In contrast, the other -MBD-GATAD2-CHD -has a 1:1:1 stoichiometry, is inherently asymmetric, and contributes the ATP-dependent remodeling activity.
A central question regarding the architecture of the NuRD complex has been how the symmetric 2:2:4 MTA-HDAC-RBBP module and the inherently asymmetric 1:1:1 MBD-GATAD2-CHD unit are connected. Our data show that MBD alone is insufficient to 'break the symmetry' of MTA-HDAC-RBBP and it is the recruitment of GATAD2 that leads to asymmetry in the full complex.
GATAD2 is also responsible for the recruitment of a CHD subunit to the complex (25) , via an interaction that is mediated by the GATA-type zinc finger of GATAD2 (26) . We do not observe GATAD2 binding to MTA, HDAC or RBBP (25) , and thus the means by which GATAD2 prevents a second copy of MBD from binding to MTA-HDAC-RBBP remains unclear. It is possible that the binding of GATAD2 to one MBD sterically blocks access to the second MTA subunit without involving a direct GATAD2-MTA interaction.
The modular nature of the NuRD complex is functionally relevant. We have shown recently that the coregulator PWWP2A can selectively bind the MTA1-HDAC-RBBP module and likely deacetylates H3K27 and H2A.Z (42) . Here, we demonstrate that the PWWP2A-MTA1-HDAC-RBBP interaction effectively rejects the MBD-GATAD2-CHD subunits by competing directly with MBD for binding to a common surface on MTA. Recent work on PWWP2A/B suggests that two copies of PWWP2A/B interact with MTA-HDAC-RBBP (51), mirroring the 2:2:2 stoichiometry we see for MTA-HDAC-MBD. Thus, the MTA-HDAC-RBBP module appears to have a cellular function independent of the intact NuRD complex, with the MTA subunit acting as a regulatory control point for competitive interactions that can lead to NuRD-independent activities for NuRD subcomplexes.
Our stoichiometry and XLMS data, combined with published findings, allows us to present a structural model for the region of the NuRD complex comprising MTA N , HDAC, MBD MBD , and the MBD CC -GATAD2 CC1 coiled-coil domain. The model, which is additionally consistent with our lowresolution electron microscopy data, significantly extends our understanding of NuRD architecture and delineates the region that acts as the point of connection between the deacetylase and remodelling modules, as well as other interacting partners.
The NuRD complex is dynamic
Our EM data indicate that the NuRD complex does not exist in a single well-defined conformation.
The MTA-HDAC-RBBP, NuDe and NuRD complexes appear to exhibit substantial conformational heterogeneity, indicating that the RBBP subunits are a major source of structural dynamics.
Consistent with this conclusion, our quantitative MS data and published structural data (29, 30) RBBPs also work as adaptors for interactions with transcriptional regulators (e.g., FOG1 (22), ZNF827 (52), PHF6 (53)), which could help guide the NuRD complex to specific genomic sites.
Considering that CHD and GATAD2 subunits together make up 25% of the mass of the NuRD complex, the lack of inter-subunit crosslinks to CHD and the C-terminal half of GATAD2 was unexpected and suggests that these subunits are even more dynamic than the RBBPs relative to the HDAC-MTA core. This conclusion is in accord with our EM data for the intact NuRD complex, which showed a smaller than expected increase in particle size compared to the subcomplexes. It is notable that the GATAD2 and CHD subunits have large regions of sequence that are predicted to be intrinsically disordered, and that the recent structure of CHD4 bound to a nucleosome (32) displayed density for only roughly a third of the protein. NuRD complexes operate at different stages of mammalian brain development (Nitarska et al., 2016). Furthermore, PWWP2A exhibits a preference for an MTA-HDAC-RBBP complex built on MTA1, rather than MTA2 (54) . The NuRD complex that we isolate from MEL cells shows a distinct preference for HDAC1 over HDAC2 and both MTA3 and MBD2 are essentially absent from our complex (Figure S1c) . The functional consequences of this subunit selectivity remain to be elucidated.
In summary, our data demonstrate that the NuRD complex is a highly dynamic assembly made from symmetric and asymmetric units that carry distinct and separable enzymatic activities. The interface between these units serves as a regulatory focal point in complex assembly, and direct competition with other transcriptional coregulators can lead to the MTA-HDAC-RBBP deacetylase module moonlighting independent of the full NuRD complex.
METHODS
Plasmids
Constructs used in this work have been previously described in (25, 28) . Additional constructs for human GATAD2A (Q8CHY6) and human PWWP2A (Q96N64) were similarly cloned into the pcDNA3.1 expression vector to generate FLAG-and HA-tagged proteins.
MTA-HDAC-RBBP, MTA N -HDAC-MBD GATAD2CC , MTA C -RBBP, MTA-HDAC-MBD-GATAD2, and PWWP2A-MTA-HDAC-RBBP expression and purification
Co-transfection, and transient overexpression of proteins in suspension HEK Expi293F TM cells (Thermo Fisher), and purification by FLAG-affinity pulldowns were essentially performed as previously described in (25) 
NuDe and NuRD purification
Samples of NuDe and NuRD were isolated by FOG1 affinity pulldown from cultured mouse erythroleukemia (MEL) cells as described in (44) .
Sucrose density gradient ultracentrifugation and fractionation
Sucrose density gradients for both GraFix (55) and non-GraFix samples were performed essentially as described in (28) . Either a 5.5 mL SW55 Ti or a 12 mL SW41 Ti Beckman Coulter rotor was used.
Crosslinking-mass spectrometry (XLMS)
Sample preparation for XLMS using disuccinimidyl suberate (DSS) and adipic acid dihydrazide (ADH) crosslinkers were essentially as described previously (28) . Crosslinking reactions using bissulfosuccinimidyl suberate (BS3) were performed essentially as described for DSS crosslinking with the exception that a 50 mM stock was made in Milli-Q water instead of dimethylformamide. XLMS data for the MTA C -RBBP complex were recorded previously (28) .
Post
Sample preparation, LC-MS/MS data collection and database searches were essentially performed as described previously (28) , with exceptions that mass analyses were performed using either a Q-Exactive or Q-Exactive Plus mass spectrometer (ThermoFisher Scientific). Mass spectrometer settings were essentially the same as previously published (28) .
For the database searches, all taxonomies in the UniProt database (Nov 2013 -Jul 2016; 541,762-551,705 entries) were searched.
Analysis of XLMS data
Analysis of the XLMS data was performed with pLINK v2.3.5 (56) . pLINK search parameters and data analysis were essentially the same as (28) with the following differences: Peptide mass between 600-10,000 Da and peptide length between 6-100 were considered, up to three missed cleavages were allowed, BS3/DSS crosslinking sites were Lys, Ser, Tyr, Thr and protein Nterminus. The default FDR of 5% was used. Only peptides with a precursor mass error of ≤ ±10 ppm, E-value scores of ≤ 1x10 -3 , and with at least four fragment ions on both the alpha-and betachain each were retained for further analysis.
For crosslinking schematics as shown in Figure S4a , the xVis webserver was used (57) .
For modeling, the list of XLs was further filtered to remove redundant hits and crosslinked intraprotein residues of ≤ 10 residues apart were discarded. This final non-redundant list and unfiltered pLINK search outputs can be found in Supplementary Data 1. All mass spectrometry data and XLMS search results have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository (58) with the dataset identifier PXD010111. The data were searched with oxidation (M) and carbamidomethyl (C) as variable modifications using a precursor-ion and product-ion mass tolerance of ± 20 ppm and ± 0.02 Da. All results were filtered using Percolator to a false discovery rate of 1%.
Data-independent acquisition mass spectrometry and sample preparation
All DIA data were processed using Skyline v3.5.0.9319 (59) . Reference spectral libraries were built in Skyline with .msf files using the BiblioSpec algorithm (60) . Precursor and product ion extracted ion chromatograms were generated using extraction windows that were two-fold the full-width at half maximum for both MS1 and MS2 filtering. Ion-match tolerance was set to 0.055 m/z. For MS1 filtering, the first three isotopic peaks with charges +2 to +4 were included while for MS2, b-and ytype fragments ions with charges +1 to +3 were considered. To ensure correct peak identification and assignment, the following criteria had to be met: All data analyses were performed using the ASTRA ® software (v6.1.1.17; Wyatt Technology).
SEC-MALLS experiments and data analysis
Both light scattering and UV data were used to calculate the molecular mass. Extinction coefficients (mL/(mg cm), at 280 nm) used were 1.148 for NuDe, 1.118 for NuRD, 1.044 for MTA N -HDAC-MBD GATAD2CC , 1.069 for bovine thyroglobulin and 0.614 for BSA. The BSA runs (untreated, 100 μ L, 2 mg/mL) were used to align the UV and light scattering signals.
To calibrate the expected mass gain from glutaraldehyde crosslinking, we applied the following formula to the BSA and thyroglobulin standards:
. As there are 59 and 148 lysine residues in BSA and thyroglobulin, respectively, we arrived at the conclusion that the GraFix protocol added an average of ~540 Da per lysine residue (Supplementary Results) .
EM sample preparation
Post-sucrose density gradient separation, crosslinked fractions containing the complex of interest 
EM image processing and 3D reconstruction
All data processing was carried out using the SPHIRE (61) and RELION 2.0 software package (62) .
A total of 325, 469, 400 and 1332 micrographs were recorded for MTA N -HDAC-MBD GATAD2CC , MTA-HDAC-RBBP, NuDe and NuRD samples, respectively. For each data set, a subset of images was used for manual picking of around 1000 particles, subsequently used to generate templates for autopicking the complete data sets, with the exception of NuRD which was picked fully manually.
The total number of extracted particles was 49216, 25155, 21622 and 124364 for MTA N -HDAC-MBD GATAD2CC , MTA-HDAC-RBBP, NuDe and NuRD, respectively. Various unsupervised 2D classifications were performed in order to select out poor quality particles (e.g., obvious aggregates, small particles).
For 3D classification and refinement of MTA N -HDAC-MBD GATAD2CC , reference-free 2D classes that had the highest distribution were selected for 3D classification. The 3D reference model used was a low pass filtered to 60 Å of the crystal structure of the MTA1 -HDAC1 dimer (PDB: 4BKX).
A single 3D class was produced containing 8233 particles, and final map was 3D refined and postprocessed. The resolution of the final map was estimated at the post-processing stage using goldstandard Fourier shell correlation. All single particle image processing was performed with no symmetry assumed or imposed.
Interaction studies using pulldown assays
Pulldown assays and western blot analyses used for the MTA N -HDAC-MBD GATAD2CC subcomplex (in Figure S5 ) and PWWP2A interaction studies (in Figure 5 ) were performed essentially as described in (25) for proteins produced in HEK293 cells. Antibodies used for the western blots were from Cell Signalling Technology: anti-HA-HRP (2999S, 1:40,000) and anti-HDAC1-HRP (59581S, 1:80,000); from Sigma-Aldrich: anti-FLAG-HRP (A8592, 1:80,000); from Abcam: anti-MBD3 (ab157464, 1:2,500); from Leinco Technologies: anti-rabbit-HRP (R115, 1:10,000).
Structural modeling
To model the MTA N -HDAC-MBD GATAD2CC subcomplex, we combined the 3D structures available for NuRD subunits, XLMS data and our SPEM map. The structures used in our modeling were MTA1 ES -HDAC1 (PDB: 4BKX), MBD domain of MBD3 (PDB: 2MB7) and MBD-GATAD2 coiled coil (PDB: 2L2L). For two NuRD regions, we constructed homology models using the SWISS-MODEL server (63) . MTA1 BAH domain was based on the structure of the Sir3 BAH domain (PDB: 2FVU); and the MTA1 ZF domain was generated based on the C-terminal ZF of GATA1 (PDB: 2GAT). Finally, a single α-helix was built in PyMOL to represent the predicted helical region for MTA1(334-354).
Modeling was performed using HADDOCK 2.4 (48), these six described models and our XLMS data. Default run parameters were used with a high distance restrain of 5 Å between MTA-BAH(164) and MTA-ELM(165), as well as between MTA-SANT(333) and MTA-helix(334).
Resulting model was analyzed in Chimera (64), using the XLinkAnalyzer tool (65) , and in PyMOL (The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC.). After building one copy of MTA-HDAC-MBD-GATAD2cc, we used two-fold symmetry to generate a second copy and build a model for the 2:2:2 MTA N -HDAC-MBD GATAD2CC complex.
Haddock modelling of the MTA C -RBBP 2 unit using previously published XLs (28) and XLs from this work was also performed. Based on existing structures of MTA R1 -RBBP and MTA R2 -RBBP complexes (Figure S1b) , we extended the length of the MTA1 fragment in the latter structure in silico by drawing on sequence similarity to the longer MTA1 R1 . From the 71 XLs observed for the MTA C -RBBP 2 unit, forty involved the region of MTA1 between R1 and R2 (residues 560-650), which is predicted to be disordered. Of the remaining XLs, three are unambiguous inter-subunit XLs between RBBP4 and RBBP7, demonstrating that 'mixed' complexes can form that contain more than one paralogue of a subunit. Although we had a model for the MTA C -RBBP 2 unit from our previously published work (28), we performed new modeling here, taking into account the new MTA1 R1 -RBBP4 structure (30) . No atomic model of MTA C -RBBP 2 was able to fulfil all the XLs. The wire mesh indicates regions of the map for which no model density is currently assigned; these regions could accommodate the C-terminal ~100 residues HDAC and ~145 residues of MBD3 IDR , for which no structure is available. Observed XLs that can be mapped with existing structural data. 42 
